Yhdysvallat - englanti - NLM (National Library of Medicine)

zoetis inc. - oxytetracycline hydrochloride (unii: 4u7k4n52zm) (oxytetracycline anhydrous - unii:slf0d9077s), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - oxytetracycline hydrochloride 5 mg in 1 g - terramycin is indicated for the prophylaxis and local treatment of superficial ocular infections due to oxytetracycline and polymyxin-sensitive organisms, including infections due to streptococci, rickettsiae, e. coli, and a. aerogenes, such as conjunctivitis, keratitis, pink eye, corneal ulcer, blepharitis in dogs, cats, cattle, sheep, and horses; ocular infections due to secondary bacterial complications of distemper in dogs, and bacterial inflammatory conditions which  may occur secondary to other infectious diseases in the above species.

Yhdysvallat - englanti - NLM (National Library of Medicine)

aspen veterinary resources - oxytetracycline hydrochloride (unii: 4u7k4n52zm) (oxytetracycline anhydrous - unii:slf0d9077s) - oxytetracycline anhydrous 100 mg in 1 ml - a great many of the pathogens involved in cattle diseases are known to be susceptible to oxytetracycline hydrochloride therapy. many strains of organisms, however, have shown resistance to oxytetracycline. in the case of certain coliforms, streptococci and staphylococci, it may be advisable to conduct culture and sensitivity testing to determine susceptibility of the infecting organism to oxytetracycline. in this manner, the likelihood of successful treatment with terra-vet™ 100 solution can be determined in advance.

Yhdysvallat - englanti - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg - moxifloxacin hydrochloride is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]) ,   haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies ( 14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. moxifloxacin hydrochloride is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies ( 14.4 )]. moxifloxacin hydrochloride is indica

Yhdysvallat - englanti - NLM (National Library of Medicine)

durvet, inc. - oxytetracycline hydrochloride (unii: 4u7k4n52zm) (oxytetracycline anhydrous - unii:slf0d9077s) - oxytetracycline anhydrous 100 mg in 1 ml - a great many of the pathogens involved in cattle diseases are known to be susceptible to oxytetracycline hydrochloride therapy. many strains of organisms, however, have shown resistance to oxytetracycline. in the case of certain coliforms, streptococci and staphylococci, it may be advisable to conduct culture and sensitivity testing to determine susceptibility of the infecting organism to oxytetracycline. in this manner, the likelihood of successful treatment with duramycin-100 solution can be determined in advance.

Yhdysvallat - englanti - NLM (National Library of Medicine)

pharmgate animal health - chlortetracycline hydrochloride (unii: o1gx33on8r) (chlortetracycline - unii:wck1kiq23q) - chlortetracycline hydrochloride 0.141 g in 1 g - indications and directions for use medicate chickens and turkeys continuously at the first clinical signs of disease and continue for 7 to 14 consecutive days. the dosage ranges permitted provide for different levels based on the severity of the infection. if improvement is not noted in 24-48 hours, consult a veterinarian or a diagnostic laboratory to determine diagnoses and for advice regarding the optimal level of the drug where ranges are permitted. water medicators: dissolve the contents of one 25.6 oz packet in 100 oz of fresh water to prepare a stock solution, that when metered at the rate of 1 oz per gallon of drinking water, will deliver 1000 mg of chlortetracycline hcl per gallon. at this rate, a gallon of drinking water will treat a 100 lb pig or a 100 lb calf at the rate of 10 mg per lb of body weight for one day.

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

bimeda animal health limited - oxytetracycline hydrochloride - solution for injection - 10 percent weight/volume - oxytetracycline

Yhdysvallat - englanti - NLM (National Library of Medicine)

quo vademus - chlortetracycline hydrochloride (unii: o1gx33on8r) (chlortetracycline - unii:wck1kiq23q) - chickens control of infectious synovitis caused by m. synoviae - 200 to 400 mg chlortetracycline hydrochloride per gallon drinking water (5.0 - 13.4 mg/lb body weight per day). control of chronic respiratory disease (crd) and air sac infections caused by m. gallisepticum and e. coli - 400 to 800 mg chlortetracycline hydrochloride per gallon drinking water (10.0 - 26.8 mg/lb body weight per day). turkeys control of infectious synovitis caused by m. synoviae - 400 mg chlortetracycline hydrochloride per gallon drinking water (3.2 - 16.8 mg/lb body weight per day). control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) - 25 mg chlortetracycline hydrochloride per pound body weight daily. swine control and treatment of bacterial enteritis (scours) caused by e. coli and salmonella spp. and bacterial pneumonia associated with pasteurella spp., actinobacillus pleuropneumonia , klebsiella spp. - 10 mg chlortetracycline hydrochloride per pound body w

Yhdysvallat - englanti - NLM (National Library of Medicine)

par pharmaceutical, inc. - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth cation - unii:zs9cd1i8ye), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules and other antibacterial drugs, bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules should be used to treat only indicated infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may

Yhdysvallat - englanti - NLM (National Library of Medicine)

pharmaka generics inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline hydrochloride tablets are indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline hydrochloride tablets should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae , mycoplasma pneumoniae (eaton agent, and klebsiella sp .) - skin and soft tissue infections caused by streptococcus pyogenes , staphylococcus aureaus . (tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections.) - infections caused by rickettsia including rocky mountain spotted fever, typhus group infections, q fever, rickettsialpox. - psittacosis caused by chlamydophila psittaci . - infections caused by chlamydia trachomatis such as uncomplicated urethral, endocervical or rectal infections, inclusion conjunctivitis, trachoma, and lymphogranuloma venereum. - granuloma inquinale caused by klebsiella granulomatis . - relapsing fever caused by borrelia sp. - bartonellosis caused by bartonella bacilliformis . - chancroid caused by hemophilus ducreyi . - tularemia caused by francisella tularensis . - plaque caused by yersinia pestis . - cholera caused by vibrio cholerae . - brucellosis caused by brucella species (tetracycline hydrochloride tablets may be used in conjunction with an aminoglycoside). - infections due to campylobacter fetus . - as adjunctive therapy in intestinal amebiasis caused by entamoeba histolytica . - urinary tract infections caused by susceptible strains of escherichia coli , klebsiella , etc. - other infections caused by susceptible gram-negative organisms such as e. coli , enterobacter aerogenes , shigella sp., acinetobacter sp ., klebsiella sp ., and bacteroides sp. - in severe acne, adjunctive therapy with tetracycline hydrochloride tablets may be useful. when penicillin is contraindicated, tetracyclines are alternative drugs in the treatment of the following infections: - syphilis and yaws caused by treponema pallidum and pertenue , respectively, - vincent's infection caused by fusobacterium fusiforme , - infections caused by neisseria gonorrhoeae, - anthrax caused by bacillus anthracis, - infections due to listeria monocytogenes, - actinomycosis caused by actinomyces species, - infections due to clostridium species. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

kela n.v. - oxytetracycline hydrochloride - solution for injection - 200 milligram(s)/millilitre - oxytetracycline - cattle - antibacterial